Home
 /
Papers
 /
Neuroscience
 /
Heterochronic myeloid cell replacement reveals the local brain environment as key driver of microglia aging
Preprint
Open access
V1
Top 1% · Validated by QED

Heterochronic myeloid cell replacement reveals the local brain environment as key driver of microglia aging

Claire Gizowski, Galina Popova, Heather Shin +23 more
September 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.09.02.673859
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Neuroscience this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By proving the aged brain environment—not intrinsic programming—drives microglial aging, and pinpointing NK cells and STAT1 as mechanistic levers, this work overturns a core assumption and makes aging phenotypes directly targetable.

QED claims analysis

Summary

The local brain environment, rather than cell-intrinsic programming, is the primary driver of microglia aging phenotypes, as demonstrated by heterochronic myeloid cell replacement showing that young donor cells rapidly acquire region-specific aging signatures in aged brains through STAT1-mediated interferon signaling driven by natural killer cells.

See full analysis
Main Claim 1 –

Expanded HSCs Enable Scalable Heterochronic CNS Myeloid Replacement

Supporting evidence

  • Cerebellar Microglia Show Stronger Aging-Linked Interferon Response Than Cortex
  • Reconstituted Myeloid Cells Recapitulate Region-Specific Microglial Identity and Tiling
Main Claim 2 –

Young Myeloid Cells Acquire Aging in Aged Cerebellum

Supporting evidence

  • Brain Environment Overrides Donor Age, Sex, and Transplant Method
  • Local Brain Environment Dominates Over Cell-Autonomous Microglia Aging Programs
Main Claim 3 –

STAT1 Signaling Drives Aging Trajectories in Reconstituted Myeloid Cells

Main Claim 4 –

NK Cells Drive Age-Related Interferon Signaling in Cerebellar Microglia

Supporting evidence

  • NK Cells Predicted as Primary IFN-γ Source to Aging Microglia
  • Lymphocyte Loss Blocks Interferon Signaling Without Reducing DAM Genes
  • Removing T and B Cells Fails to Reduce Microglial Interferon Aging

Abstract

Aging, the key risk factor for cognitive decline, impacts the brain in a region-specific manner, with microglia among the most affected cell types. However, it remains unclear whether this is intrinsically mediated or driven by age-related changes in neighboring cells. Here, we describe a scalable, genetically modifiable system for in vivo heterochronic myeloid cell replacement. We find reconstituted myeloid cells adopt region-specific transcriptional, morphological and tiling profiles characteristic of resident microglia. Young donor cells in aged brains rapidly acquired aging phenotypes, particularly in the cerebellum, while old cells in young brains adopted youthful profiles. We identified STAT1-mediated signaling as one axis controlling microglia aging, as STAT1-loss prevented aging trajectories in reconstituted cells. Spatial transcriptomics combined with cell ablation models identified rare natural killer cells as necessary drivers of interferon signaling in aged microglia. These findings establish the local environment, rather than cell-autonomous programming, as a primary driver of microglia aging phenotypes.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?